Patents by Inventor Claire Daugherty

Claire Daugherty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cobalamin Taxane Bioconjugates
    Publication number: 20120015900
    Abstract: The present invention is directed to methods and compositions including a taxane covalently bonded to the cobalt atom of a cobalamin. The composition can be delivered by any effective route, but is particularly useful as an oral anti-cancer or antiangiogenic compound. The anti-cancer/anti-angiogenic compound can be used in various chemotherapies including anti-angiogenic chemotherapies, alone or in combination with other anti-cancer/anti-angiogenic compounds.
    Type: Application
    Filed: July 22, 2011
    Publication date: January 19, 2012
    Applicant: Osiris Therapeutics, Inc.
    Inventors: John R. Gebhard, David Vollmer, Claire Daugherty, Dinesh Patel
  • Cobalamin taxane bioconjugates
    Publication number: 20080233135
    Abstract: The present invention is directed to methods and compositions including a taxane covalently bonded to the cobalt atom of a cobalamin. The composition can be delivered by any effective route, but is particularly useful as an oral anti-cancer or antiangiogenic compound. The anti-cancer/anti-angiogenic compound can be used in various chemotherapies including anti-angiogenic chemotherapies, alone or in combination with other anti-cancer/anti-angiogenic compounds.
    Type: Application
    Filed: March 14, 2008
    Publication date: September 25, 2008
    Inventors: John R. Gebhard, David Vollmer, Claire Daugherty, Dinesh Patel
  • Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating cancer
    Publication number: 20060217355
    Abstract: The present invention is related to therapeutic uses of dehydroepiandrosterone (DHEA) congeners. More specifically, the present invention relates to the co-administration of a dehydroepiandrosterone (DHEA) congener in combination with at least one other pharmaceutically active agent to treat or prevent cancer.
    Type: Application
    Filed: March 6, 2006
    Publication date: September 28, 2006
    Inventors: Dinesh Patel, David Vollmer, Claire Daugherty, John Gebhard
  • Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating depression
    Publication number: 20060154908
    Abstract: The present invention is drawn to compositions and methods for treating depression in a subject comprising co-administering therapeutically effective amounts of a DHEA congener and a second antidepressant agent to the subject, wherein the step of co-administrating is more effective in producing an anti-depressive effect compared to the administration of either the DHEA congener or the second antidepressant agent alone at their respective dosages.
    Type: Application
    Filed: January 26, 2006
    Publication date: July 13, 2006
    Inventors: Dinesh Patel, David Vollmer, Claire Daugherty, John Gebhard
  • Co-administration of dehydroepiandrosterone (DHEA) congener with parthenolide for treating inflammation
    Publication number: 20060122160
    Abstract: The present invention is related to therapeutic uses of dehydroepiandrosterone (DHEA) congeners. More specifically, the present invention relates to the co-administration of a dehydroepiandrosterone (DHEA) congener in combination with a parthenolide to reduce inflammation.
    Type: Application
    Filed: November 8, 2005
    Publication date: June 8, 2006
    Inventors: Dinesh Patel, David Vollmer, Claire Daugherty, John Gebhard
  • Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation
    Publication number: 20060004076
    Abstract: The present invention is related to therapeutic uses of dehydroepiandrosterone (DHEA) congeners. More specifically, the present invention relates to the co-administration of a dehydroepiandrosterone (DHEA) congener in combination with at least one other pharmaceutically active agent to reduce inflammation.
    Type: Application
    Filed: June 3, 2005
    Publication date: January 5, 2006
    Inventors: Dinesh Patel, David Vollmer, Claire Daugherty, John Gebhard